Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Sheppard

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancerK Boelaert, C J McCabe, L A Tannahill, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based studyJ M Heward, A Allahabadia, J Daykin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumorsC J McCabe, K Boelaert, L A Tannahill, et al.
Clinical Endocrinology|February 13, 2003
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviourC J McCabe, J S Khaira, K Boelaert, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33J M Heward, A Allahabadia, M Armitage, et al.
European Journal of Endocrinology|December 3, 2005
Consensus statement: medical management of acromegalyS Melmed, F Casanueva, F Cavagnini, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancerK Boelaert, C J McCabe, L A Tannahill, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based studyJ M Heward, A Allahabadia, J Daykin, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumorsC J McCabe, K Boelaert, L A Tannahill, et al.
Clinical Endocrinology|February 13, 2003
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviourC J McCabe, J S Khaira, K Boelaert, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33J M Heward, A Allahabadia, M Armitage, et al.
European Journal of Endocrinology|December 3, 2005
Consensus statement: medical management of acromegalyS Melmed, F Casanueva, F Cavagnini, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 24